drugset / Trial / NCT00004755
Allopurinol, Glucantime, or Allopurinol/Glucantime for Cutaneous Leishmaniasis in Brazil
Phase 2
Completed
375 enrolled
National Institute of Allergy and Infectious Diseases (NIAID)
Harvard School of Public Health (HSPH) · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
OBJECTIVE: Compare the efficacy and side effects of allopurinol versus glucantime versus allopurinol/glucantime in patients in Brazil with cutaneous leishmaniasis.
Timeline
- Start
- 1995-09
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Allopurinol | Small molecule | — | Oral |
| Subject | Meglumine antimonate | Other / unclassified | — | Intramuscular |